BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 17345146)

  • 21. Nucleoside transporters: molecular biology and implications for therapeutic development.
    Baldwin SA; Mackey JR; Cass CE; Young JD
    Mol Med Today; 1999 May; 5(5):216-24. PubMed ID: 10322314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleoside transporters: from scavengers to novel therapeutic targets.
    King AE; Ackley MA; Cass CE; Young JD; Baldwin SA
    Trends Pharmacol Sci; 2006 Aug; 27(8):416-25. PubMed ID: 16820221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of human nucleoside transporters in normal and tumor tissue.
    Pennycooke M; Chaudary N; Shuralyova I; Zhang Y; Coe IR
    Biochem Biophys Res Commun; 2001 Jan; 280(3):951-9. PubMed ID: 11162617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations.
    Gray JH; Mangravite LM; Owen RP; Urban TJ; Chan W; Carlson EJ; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; Giacomini KM
    Mol Pharmacol; 2004 Mar; 65(3):512-9. PubMed ID: 14978229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport of nucleoside analogs across the plasma membrane: a clue to understanding drug-induced cytotoxicity.
    Huber-Ruano I; Pastor-Anglada M
    Curr Drug Metab; 2009 May; 10(4):347-58. PubMed ID: 19519343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside.
    Damaraju VL; Visser F; Zhang J; Mowles D; Ng AM; Young JD; Jayaram HN; Cass CE
    Mol Pharmacol; 2005 Jan; 67(1):273-9. PubMed ID: 15486050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity.
    Leung GP; Tse CM
    Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):705-18. PubMed ID: 17916056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipophilic prodrugs and formulations of conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancer.
    Peters GJ; Adema AD; Bijnsdorp IV; Sandvold ML
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1168-80. PubMed ID: 22132972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes.
    Cabrita MA; Baldwin SA; Young JD; Cass CE
    Biochem Cell Biol; 2002; 80(5):623-38. PubMed ID: 12440702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular biology of nucleoside transporters and their distributions and functions in the brain.
    Parkinson FE; Damaraju VL; Graham K; Yao SY; Baldwin SA; Cass CE; Young JD
    Curr Top Med Chem; 2011; 11(8):948-72. PubMed ID: 21401500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of nucleoside transporters using novel autofluorescent nucleoside probes.
    Zhang J; Sun X; Smith KM; Visser F; Carpenter P; Barron G; Peng Y; Robins MJ; Baldwin SA; Young JD; Cass CE
    Biochemistry; 2006 Jan; 45(4):1087-98. PubMed ID: 16430205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae.
    Zhang J; Visser F; Vickers MF; Lang T; Robins MJ; Nielsen LP; Nowak I; Baldwin SA; Young JD; Cass CE
    Mol Pharmacol; 2003 Dec; 64(6):1512-20. PubMed ID: 14645682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleoside transporters of mammalian cells.
    Cass CE; Young JD; Baldwin SA; Cabrita MA; Graham KA; Griffiths M; Jennings LL; Mackey JR; Ng AM; Ritzel MW; Vickers MF; Yao SY
    Pharm Biotechnol; 1999; 12():313-52. PubMed ID: 10742981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney.
    Mangravite LM; Badagnani I; Giacomini KM
    Eur J Pharmacol; 2003 Oct; 479(1-3):269-81. PubMed ID: 14612157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
    Damaraju D; Damaraju VL; Brun M; Mowles D; Kuzma M; Berendt RC; Sawyer MB; Cass CE
    Biochem Pharmacol; 2008 May; 75(10):1901-11. PubMed ID: 18371936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The concentrative nucleoside transporter family, SLC28.
    Gray JH; Owen RP; Giacomini KM
    Pflugers Arch; 2004 Feb; 447(5):728-34. PubMed ID: 12856181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of transporters in the toxicity of nucleoside and nucleotide analogs.
    Koczor CA; Torres RA; Lewis W
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):665-76. PubMed ID: 22509856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New nucleoside analogs in the treatment of solid tumors.
    Szafraniec SI; Stachnik KJ; Skierski JS
    Acta Pol Pharm; 2004; 61(4):297-305. PubMed ID: 15575597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug transporters relevant to HIV therapy.
    Thomas SA
    J HIV Ther; 2004 Nov; 9(4):92-6. PubMed ID: 15731741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of mENT1Delta11, a novel alternative splice variant of the mouse equilibrative nucleoside transporter 1.
    Robillard KR; Bone DB; Park JS; Hammond JR
    Mol Pharmacol; 2008 Jul; 74(1):264-73. PubMed ID: 18413666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.